Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Juli 2022

Biotek-snakken — Juli 2022

Planlagt Fastgjort Låst Flyttet Biotek-snakken
80 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #21

    vallidering

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #22

      Just a moment...

      favicon

      (firstwordpharma.com)

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #23

        Bliver spændende at læse denne:

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #24

          In the second-line setting, HER2-positive patients can now be treated with AstraZeneca and Daiichi Sankyo's antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan), though its use is not without safety concerns.

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #25

            Key opinion leaders (KOLs) – interviewed for a new FirstWord Therapy Trends report on the current and future gastric cancer treatment landscape – are confident that confirmatory Phase III trial data will read out positively to cement its status as a second-line treatment option, but are less enthusiastic about its potential role in the first-line setting.

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #26

              Håber at Zanidatamab kan få foden ind i første linie, men der er lang tid endnu og meget kan ske - dog umiddelbart positivt, hvis Enhertu ikke ses som den naturlige arvtager

              1 Reply Last reply
              0
              • L Offline
                L Offline
                lahn1
                wrote on sidst redigeret af
                #27

                Syntes ikke jeg kan få adgang til den rapport ? Kan du copy/paste lidt 🙂 ?

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #28

                  Den er ikke kommet endnu - blot en teaser

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #29

                    2 Top Healthcare Stocks to Buy Right Now https://www.proinvestor.com/investornyt/848220/2-top-healthcare-stocks-to-buy-right-now

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #30

                      Video med TA-analyse af
                      XBI,
                      Bavarian,
                      Novo Nordisk,
                      Genmab,
                      Zealand Pharma og
                      Hansa Biopharma. https://www.proinvestor.com/boards/104411/

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #31

                        Mon Sutro har noget spændende at byde på:

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #32

                          Link Preview Image
                          Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCs

                          SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will host a virtual research forum in which it will unveil the next product candidate, discuss immunostimulatory ADCs (iADCs) as a novel modality, and highlight recent enhancement to its cell-free manufacturing platform. Webcast de

                          favicon

                          Yahoo Finance (finance.yahoo.com)

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #33

                            ANALYSIS-Bruised investors seek shelter in U.S. healthcare stocks https://www.proinvestor.com/investornyt/849645/analysis-bruised-investors-seek-shelter-in-us-healthcare-stocks

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #34

                              Biotek i positiv trend. Sidste efterår begyndte grønne aktier og vækstaktier at ryge ned i kælderen kursmæssigt. Biotekaktierne fik også stryg. Men i maj begyndte nogle amerikanske biotekvirksomheder at lave bundvendinger, og siden er det begyndt at gå rigtig godt for nogle af de biotek-darlings, der er på ProInvestor.com. https://www.proinvestor.com/boards/104440

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #35

                                Godmorgen, 🙂

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #36

                                  Topchef i dansk-svensk biotekselskab fratræder - fremtiden usikker https://www.proinvestor.com/investornyt/850759/topchef-i-dansk-svensk-biotekselskab-fratraeder-fremtiden-usikker

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #37

                                    Friday Sector Laggards: Biotechnology, Precious Metals https://www.proinvestor.com/investornyt/851087/friday-sector-laggards-biotechnology-precious-metals

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      LP90
                                      wrote on sidst redigeret af
                                      #38

                                      Hej nogen herinde der er med på Anavex casen og som har en forklaring på dykket på næsten 20% i går ?

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #39

                                        Sutro´s næste kliniske kandidat STRO-003 går efter ROR1 med et ADC, men de er lidt bagefter mod dette ellers hotte target - her et par deals:

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #40

                                          301 Moved Permanently

                                          favicon

                                          (www.evaluate.com)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper